AI Revolution Is Transforming Diabetes Management In Response To Soaring Prevalence: Core Growth Enabler in the Artificial Intelligence in Diabetes Management Market, 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Artificial Intelligence in Diabetes Management Industry Market Size Be by 2025?
The size of the market for artificial intelligence in managing diabetes has seen exponential growth in recent years. It's expected to expand from $0.62 billion in 2024 to $0.8 billion in 2025, growing at a compound annual growth rate (CAGR) of 30.2%. The significant growth during the historical period can be linked to the collection of data, increased incidences of diabetes, healthcare cost pressures, and initial applications of AI.

What's the Long-Term Growth Forecast for the Artificial Intelligence in Diabetes Management Market Size Through 2029?
In the coming years, substantial growth is predicted in the market size of artificial intelligence in diabetes management. It's anticipated to surge to $2.56 billion by 2029, with an impressive compound annual growth rate (CAGR) of 33.7%. The projected growth during this period is ascribed to elements such as AI-enabled decision support systems, integration of telemedicine, usage of genomic data, and regulatory aid. Major trends during the forecast period comprise enhancements in wearable technology, tailor-made treatment schemes, advancements in continuous glucose monitoring, AI-backed risk forecasting, and backing for behavioral changes.

View the full report here:
https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-diabetes-management-global-market-report

What Are the Key Growth Drivers Fueling the Artificial Intelligence in Diabetes Management Market Expansion?
The growth of artificial intelligence in the diabetes management market is expected to be driven forward by the increasing incidence of diabetes. High levels of blood glucose or sugar in the blood signify the onset of diabetes, a disease that can lead to various complications including eye issues, heart problems, strokes, and kidney issues, among others. The function of artificial intelligence in managing diabetes is to provide information about elevated or reduced blood sugar levels in a patient with diabetes and gather previously unused data. In June 2024, the UK's National Health Service (NHS England) reported that 3,615,330 individuals registered with a GP were diagnosed with non-diabetic hyperglycaemia or pre-diabetes in 2023, compared to 3,065,825 in 2022, marking an increase of nearly 18%. Therefore, the escalating incidence rates of diabetes are fuelling the expansion of the artificial intelligence sector in diabetes management.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12593&type=smp

What Are the Key Trends Driving Artificial Intelligence in Diabetes Management Market Growth?
Cutting-edge technology is emerging as a prevalent trend in the artificial intelligence in diabetes management market. Large corporations involved in the artificial intelligence in diabetes management sector are focusing on devising unique and advanced technology solutions to retain their market status. For example, in October 2022, an innovative artificial intelligence-enabled platform for tailored diabetes care was introduced by Dr. Mohan's Diabetes Specialties Center, a chain of diabetes specialty hospitals situated in India. The center is implementing the 3D Initiative, beginning with DIA, an AI-driven chatbot that assists individuals through pre-recorded digital communication. Following DIA is DIALA, a mobile application convenient for patient use; finally there's DIANA, a medical application designed for precise diabetic care. Per the organization, it encompasses the highly sophisticated Total Experience (TX) Automation Platform, which operates an AI-powered virtual assistant that engages patients on digital channels like Facebook Messenger, WhatsApp, Google Business Message, and the internet.

How Is the Artificial Intelligence in Diabetes Management Market Segmented?
The artificial intelligence in diabetes management market covered in this report is segmented -

1) By Device: Diagnostic Devices, Glucose Monitoring Devices, Insulin Delivery Devices, Other Devices
2) By Techniques: Case-Based Reasoning, Intelligent Data Analysis
3) By End-Use: Hospitals, Clinics, Home Care Settings, Research Institutes

Subsegments:
1) By Diagnostic Devices: Blood Glucose Meters, Continuous Glucose Monitors (CGMs), A1C Testing Devices, Urine Testing Devices
2) By Glucose Monitoring Devices: Continuous Glucose Monitors (CGMs), Flash Glucose Monitoring Systems, Smart Glucose Meters
3) By Insulin Delivery Devices: Insulin Pens, Insulin Pumps, Insulin Jet Injectors, Smart Insulin Delivery Systems
4) By Other Devices: Diabetes Management Apps, Wearable Devices, Smart Health Monitors, Insulin Refrigerators

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12593&type=smp

Which Companies Are Leading the Charge in Artificial Intelligence in Diabetes Management Market Innovation?
Major companies operating in the artificial intelligence in diabetes management market include Alphabet Inc., F. Hoffmann-La Roche AG, Abbott Laboratories, Medtronic Plc, Dexcom Inc., Insulet Corporation, Tandem Diabetes Care Inc., LifePlus Inc., Livongo Health Inc., Xeris Pharmaceuticals Inc., Virta Health Corp., Informed Data Systems Inc., Bigfoot Biomedical Inc., Lark Technologies Inc., Smart Meter LLC, Diabeloop SA, Quin Technology Ltd., Wellthy Therapeutics Pvt Ltd., Admetsys LLC, DreaMed Diabetes Ltd., Eyenuk Inc., Glooko Inc., PKvitality, Glytec LLC, Hygieia Inc., TypeZero Technologies Inc., Nemaura Medical Inc., GlucoMe, PredictBGL, Voluntis S.A.

Which Regions Are Leading the Global Artificial Intelligence in Diabetes Management Market in Revenue?
North America was the largest region in the artificial intelligence (AI) in diabetes management market in 2024. The regions covered in the artificial intelligence in diabetes management market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12593

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe - +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email: info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.